Kyverna Therapeutics (KYTX) Shares Outstanding (Diluted) (2023 - 2026)
Kyverna Therapeutics' Shares Outstanding (Diluted) was 60.9 million in Q2 2026, up 40.9% from 43.23 million a year earlier and up 0.8% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Kyverna Therapeutics came in at 44.26 million, up 15.5% from FY2024.
- In earlier years, Shares Outstanding (Diluted) was 38.33 million in FY2024 and 673,622 in FY2023.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2023.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for six straight quarters, with growth averaging 29.8% over the last six quarters.
- Per Business Quant data, KYTX's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 60.43 million (Q1 2026), 44.26 million (Q4 2025) and 43.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Kyverna Therapeutics | 401.44 Mn | 401.44 Mn | - | 60.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.90 Mn |
| Mar 31, 2026 | 60.43 Mn |
| Dec 31, 2025 | 44.26 Mn |
| Sep 30, 2025 | 43.42 Mn |
| Jun 30, 2025 | 43.23 Mn |
| Mar 31, 2025 | 43.22 Mn |
| Dec 31, 2024 | 38.33 Mn |
| Sep 30, 2024 | 43.16 Mn |
| Jun 30, 2024 | 43.13 Mn |
| Mar 31, 2024 | 23.75 Mn |
| Dec 31, 2023 | 673,622.00 |
| Sep 30, 2023 | 664,656.00 |
| Jun 30, 2023 | 627,589.00 |
| Mar 31, 2023 | 921,260.00 |
API Access
Kyverna Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();